Design approaches to drug discovery

A series of projects commissioned by pharmaceutical company ArQule (originally for the startup company Camitro, acquired by ArQule in the course of the work) explored the potential for visualisation of probability spaces resulting from quantum simulation of drug compound behaviours, combining these with a sociological exploration of the laboratories within such data was used. The results were developed through an interaction design process into products that continue to be influential, most recently in the foundation of Cambridge company Optibrium by members of the team.

Crucible collaborators:

• Matt Segall
• Alan Blackwell
• Rachel Hewson
• Ed Champness
• Brett Saunders
• Andrew Barry
• Georgina Born